Recent Updates
Recently added Catalysts
ADMA Negative Sentiment Score: 20/100

ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Key Takeaway: Rosen Law Firm is investigating potential securities claims on behalf of shareholders of ADMA Biologics, Inc. due to allegations of misleading business information. This follows a significant decline in the company's stock price after a report claimed that ADMA engaged in channel stuffing to inflate revenue growth. Investors who purchased ADMA securities may be eligible for compensation through a class action lawsuit led by the firm, which has gained reputation for successfully handling securities cases.

Market Sentiment Analysis

CONCERNS & RISKS

  • ADMA Biologics is facing allegations of issuing materially misleading information.
  • Shares of ADMA Biologics plummeted by 16.6% following a report by a short seller.
  • The investigation by Rosen Law Firm indicates potential legal troubles for ADMA.

Full Press Release Details

NEW YORK, May 03, 2026 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased ADMA Biologics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=57940 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
WHAT IS THIS ABOUT: On March 24, 2026, Investing.com published an article entitled “ADMA Biologics shares plunge on short seller allegations.” The article stated that ADMA Biologics shares fell “after short seller Culper Research released a report alleging the company engaged in channel stuffing to inflate revenue growth.”
On this news, ADMA Biologics stock fell 16.6% on March 24, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
Toll Free: (866) 767-3653

Tags

Frequently Asked Questions

What is the investigation by Rosen Law Firm about?

Rosen Law Firm is investigating potential securities claims against ADMA Biologics for allegedly issuing misleading business information.

How can I join the class action for ADMA Biologics?

To join the ADMA Biologics class action, visit the Rosen Law Firm’s submission page or call them.

What caused ADMA Biologics' stock to drop?

ADMA Biologics' stock fell 16.6% due to allegations of revenue inflation by short seller Culper Research.

Why choose Rosen Law Firm for representation?

Rosen Law Firm has a strong track record in securities class actions and substantial recoveries for investors.

Are there any fees if I join the class action?

Investors may be entitled to compensation without upfront fees through a contingency fee arrangement.

Last updated: May 3, 2026